FLT3 and neoplasm: After 1 week when leukaemic bioluminescent signals became detectable, the tumour‐bearing mice were treated with FLT3‐ITD ASO‐loaded RBCEVs or negative control (NC) ASO‐loaded RBCEVs systemically (i.v.)every two days.